Retatrutide | GLP-1 GIP GCG Peptides | 99% Purity | CAS 2381089-83-2 | White Powder | Weight loss

  Product Detail  

CAS No.: 2381089-83-2

Appearance:  White Powder 

Retatrutide is a chemically synthesized peptide developed as a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents a next-generation incretin research compound designed for advanced studies in energy metabolism, glucose regulation, and multi-pathway hormonal interaction mechanisms.

Mechanism of Action

Retatrutide exhibits a unique three-in-one receptor activation profile:

• GIP receptor activation: supports glucose-dependent metabolic signaling
• GLP-1 receptor activation: involved in incretin-mediated glucose regulation pathways
• Glucagon receptor activation: contributes to energy expenditure and metabolic flux regulation

This multi-target mechanism provides a broader and more integrated model for studying metabolic control systems compared to single- or dual-agonist peptides.

Comparison Advantage (vs Tirzepatide & Semaglutide)

• Compared with Tirzepatide (dual agonist):
  Retatrutide introduces an additional glucagon receptor activation pathway, providing a more comprehensive metabolic regulation model.
• Compared with Semaglutide (GLP-1 single agonist):
  Retatrutide extends beyond single-pathway incretin signaling, enabling multi-system metabolic interaction research.
• Overall advantage:
  Retatrutide serves as a triple-mechanism reference compound, offering broader research potential in metabolic science and peptide engineering. 

NOTE: It is for research use only.

Contact Us

Ms. Iris

Tel/Whatsapp：+86 13002751028

Email: Irisbian@transcoasia.com

  Company Introduction